Back to results
US 2026/0062458 A1Published application
Chimeric antigen receptor
AssigneeAutolus Limited
InventorsMartin Pulé, Kwee Yong, Lydia Lee, Ben Draper
Life of this patent
Estimating the term…
Abstract
The present invention provides a chimeric antigen receptor (CAR) comprising: (i) a B cell maturation antigen (BCMA)-binding domain which comprises at least part of a proliferation-inducing ligand (APRIL); (ii) a spacer domain (iii) a transmembrane domain; and (iv) an intracellular T cell signaling domain. The invention also provides the use of such a T-cell expressing such a CAR in the treatment of plasma-cell mediated diseases, such as multiple myeloma.
Claims21
A chimeric antigen receptor (CAR) comprising:
- (i) a B cell maturation antigen (BCMA)-binding domain which comprises at least part of a proliferation-inducing ligand (APRIL),
- (ii) a spacer domain,
- (iii) a transmembrane domain, and
- (iv) (iii) an intracellular T cell signaling domain.
1 more element
17-18. (canceled)
Dependencies are inferred from the claim text.